The Bode Lab
The Bode Lab

How to Support Us

You can now directly support our research with a tax-deductible gift to help our team identify how Human Milk Oligosaccharides benefit the breastfed neonate.

 

Read the list below that outlines our most recent accomplishments and future trajectories... Your support is going to make a significant difference in advancing these projects to the next level!

 

Gifts can be made to the UC San Diego Foundation, a tax exempt charity whose mission is to raise funds for the benefit of the University of California (UC), San Diego. The tax exempt organization tax id is 95-2872494.

 

Our gift fund in the Foundation is entitled “Research on the Benefits of Human Breast Milk” (fund number 4683).

Online Gift

If you would like to make an online gift, please click Here and you will enter a secure website for your direct gift to this fund.

 

Mail a Check

If you would like to mail a check, please make it payable to:

 

UC San Diego Foundation

9500 Gilman Drive, Mail Code 0940

La Jolla, CA 92093-0940

 

Please annotate: “Fund # 4683, Research on Human Breast Milk”

 

Questions

If you have any questions, please don’t hesitate to contact Dr. Lars Bode directly.

 

email lbode@ucsd.edu  or  call 858 246 1874

 

 

Recent Accomplishments and Trajectories

  • We discovered in animal studies that specific HMO protect from necrotizing enterocolitis, one of the most common and often fatal intestinal disorders in preterm infants. We are now testing whether these results translate to benefit the human infant.
  • We discovered that HMO block initial interactions of the human immunodeficiency virus (HIV)with human immune cells and that HMO correlate with a reduced risk of mother-to-child HIV transmission through breastfeeding. We are now testing whether these results can predict and reduce the risk of HIV transmission from an HIV-infected mother to her uninfected child.
  • We discovered that HMO interfere with early steps in the pathogenesis of amebiasis, a disease caused by a protozoan parasite that takes more than 100,000 lives each year, mostly infants and young children. We are now testing whether these oligosaccharides can be used to treat or even prevent amebiasis.
  • We discovered that HMO block several other viruses and bacteria that cause severe infections and kill thousands of infants and young children around the world. We are now testing whether these oligosaccharides can be used to treat these deadly infections, or even prevent them in the first place.
  • We discovered that HMO may not only benefit the breast-fed infant, but also the breastfeeding mother.
  • We have begun to use human milk stem cells to elucidate how HMO are synthesized in the mammary gland, one of the few biosynthetic pathways in humans that remains to be discovered.

Dedicated to Research on Human Milk Oligosaccharides

Print Print | Sitemap
© lars bode